| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Airway Obstruction | D000402 | 13 associated lipids |
| Uremia | D014511 | 33 associated lipids |
| Stomach Ulcer | D013276 | 75 associated lipids |
| Kidney Failure, Chronic | D007676 | 51 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Hypoxia | D000860 | 23 associated lipids |
| Graft Occlusion, Vascular | D006083 | 11 associated lipids |
| Arrhythmias, Cardiac | D001145 | 42 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kranzhofer R and Ruef J | Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphism. | 2006 | Platelets | pmid:16702043 |
| Chen GG et al. | Increased thromboxane B(2) levels are associated with lipid peroxidation and Bcl-2 expression in human lung carcinoma. | 2006 | Cancer Lett. | pmid:15876485 |
| Zhou Y et al. | Increased expression of cyclooxygenase-2 mediates enhanced contraction to endothelin ETA receptor stimulation in endothelial nitric oxide synthase knockout mice. | 2006 | Circ. Res. | pmid:16645140 |
| Karkabounas S et al. | Anticarcinogenic and antiplatelet effects of carvacrol. | 2006 | Exp. Oncol. | pmid:16837902 |
| Wilder-Smith CH et al. | Dose-effect comparisons of the CINOD AZD3582 and naproxen on upper gastrointestinal tract mucosal injury in healthy subjects. | 2006 | Scand. J. Gastroenterol. | pmid:16497612 |
| Brenneis C et al. | Inhibition of prostaglandin E2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition. | 2006 | FASEB J. | pmid:16816110 |
| Baltzer WI et al. | Measurement of urinary 11-dehydro-thromboxane B2 excretion in dogs with gastric dilatation-volvulus. | 2006 | Am. J. Vet. Res. | pmid:16426215 |
| Chiu HF et al. | Mechanisms involved in the antiplatelet effect of C-phycocyanin. | 2006 | Br. J. Nutr. | pmid:16469164 |
| Rossoni G et al. | Nitric oxide and prostacyclin pathways: an integrated mechanism that limits myocardial infarction progression in anaesthetized rats. | 2006 | Pharmacol. Res. | pmid:16488624 |
| Lepäntalo A et al. | Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients. | 2006 | Thromb. Haemost. | pmid:16493486 |
| Kurosawa S et al. | Effects of ulinastatin on pulmonary artery pressure during abdominal aortic aneurysmectomy. | 2006 | J Clin Anesth | pmid:16517327 |
| Flipo RM | [Are the NSAIDs able to compromising the cardio-preventive efficacy of aspirin?]. | 2006 | Presse Med | pmid:17078596 |
| Dołegowska B et al. | Metabolism of eicosanoids and their action on renal function during ischaemia and reperfusion: the effect of alprostadil. | 2006 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:17011760 |
| Ong TZ et al. | Nonsteroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: a prospective study. | 2006 | J. Clin. Gastroenterol. | pmid:17016134 |
| Morchón R et al. | High levels of serum thromboxane B2 are generated during human pulmonary dirofilariosis. | 2006 | Clin. Vaccine Immunol. | pmid:17028222 |
| Ibrahim S et al. | Transfer of very low density lipoprotein-associated phospholipids to activated human platelets. | 2006 | J. Lipid Res. | pmid:16293890 |
| Cook-Johnson RJ et al. | Endothelial cell COX-2 expression and activity in hypoxia. | 2006 | Biochim. Biophys. Acta | pmid:17046322 |
| Faraday N et al. | Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population. | 2006 | Am. J. Cardiol. | pmid:16950183 |
| Laleman W et al. | A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited. | 2006 | Eur. J. Clin. Invest. | pmid:16620286 |
| Zhao Y et al. | Effect of a Chinese herbal formula, Shi-Bi-Lin, on an experimental model of allergic rhinitis. | 2006 | Ann. Allergy Asthma Immunol. | pmid:16802773 |
| Lee KS et al. | Antiplatelet activity of [5-(2-methoxy-5-chlorophenyl)furan-2-ylcarbonyl]guanidine (KR-32570), a novel sodium/hydrogen exchanger-1 and its mechanism of action. | 2006 | Arch. Pharm. Res. | pmid:16756082 |
| Peck OM et al. | The phosphatidylinositol 3 kinase pathway regulates tolerance to lipopolysaccharide and priming responses to Staphylococcus aureus and lipopolysaccharide. | 2006 | Shock | pmid:16783195 |
| Frelinger AL et al. | Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. | 2006 | Circulation | pmid:16785341 |
| Cox D et al. | Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. | 2006 | Stroke | pmid:16794200 |
| Munsterhjelm E et al. | Influence on platelet aggregation of i.v. parecoxib and acetaminophen in healthy volunteers. | 2006 | Br J Anaesth | pmid:16698862 |
| Nakamura K et al. | Effects of atorvastatin and aspirin combined therapy on inflammatory responses in patients undergoing coronary artery bypass grafting. | 2006 | Cytokine | pmid:17300951 |
| Vranic II et al. | Adenosine cardioprotection study in clinical setting of paroxysmal supraventricular tachycardia. | 2006 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:16682179 |
| Huntjens DR et al. | Correlation between in vitro and in vivo concentration-effect relationships of naproxen in rats and healthy volunteers. | 2006 | Br. J. Pharmacol. | pmid:16682968 |
| Park HS et al. | Dietary trans-10, cis-12 and cis-9,trans-11 conjugated linoleic acids induce apoptosis in the colonic mucosa of rats treated with 1,2-dimethylhydrazine. | 2006 | J Med Food | pmid:16579724 |
| Ohmori T et al. | Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. | 2006 | J. Thromb. Haemost. | pmid:16706971 |
| Perneby C et al. | Dose- and time-dependent antiplatelet effects of aspirin. | 2006 | Thromb. Haemost. | pmid:16601836 |
| Basili S et al. | Insulin resistance as a determinant of platelet activation in obese women. | 2006 | J. Am. Coll. Cardiol. | pmid:17174194 |
| Hrushka NH et al. | [Effect of thromboxane B2 on morphological features of apoptosis in cultured rat hepatocytes exposed to hepatotropic substances]. | 2006 | Fiziol Zh | pmid:17176837 |
| Niemi TT et al. | The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm. | 2006 | Blood Coagul. Fibrinolysis | pmid:16607076 |
| Chiang N and Serhan CN | New mechanism for an old drug: aspirin triggers anti-inflammatory lipid mediators with gender implications. | 2006 | Compr Ther | pmid:17435267 |
| Stergioulas AT and Filippou DK | Effects of physical conditioning on lipids and arachidonic acid metabolites in untrained boys: a longitudinal study. | 2006 | Appl Physiol Nutr Metab | pmid:16900233 |
| Fujimoto Y et al. | Monochloramine potently inhibits arachidonic acid metabolism in rat platelets. | 2006 | Biochem. Biophys. Res. Commun. | pmid:16615995 |
| Xu S et al. | The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice. | 2006 | Diabetes | pmid:16380483 |
| Sánchez M et al. | Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. | 2006 | J. Hypertens. | pmid:16331104 |
| Chiang N et al. | Aspirin has a gender-dependent impact on antiinflammatory 15-epi-lipoxin A4 formation: a randomized human trial. | 2006 | Arterioscler. Thromb. Vasc. Biol. | pmid:16293793 |
| Wolfram RM et al. | Salivary isoprostanes indicate increased oxidation injury in periodontitis with additional tobacco abuse. | 2006 | Biofactors | pmid:17264390 |
| González-Correa JA et al. | Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood. | 2005 May-Jun | Platelets | pmid:16011961 |
| Zhao Y et al. | [The effect of desloratadine on the TXB2 and leukotrienes levels in the nasal lavage fluid of allergic rhinitis animal model]. | 2005 | Lin Chuang Er Bi Yan Hou Ke Za Zhi | pmid:16075993 |
| Yoshino T et al. | Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor. | 2005 | Arzneimittelforschung | pmid:16080279 |
| Mancini F et al. | Time since menopause does not affect plasma viscosity, plasma thromboxane levels and Doppler findings. | 2005 | Gynecol. Endocrinol. | pmid:16019357 |
| Mancini F et al. | Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers. | 2005 | Gynecol. Endocrinol. | pmid:16019365 |
| Michibayashi T | Platelet aggregation and vasoconstriction related to platelet cyclooxygenase and 12-lipoxygenase pathways. | 2005 | J. Atheroscler. Thromb. | pmid:16020916 |
| Svenstrup Poulsen T et al. | A critical appraisal of the phenomenon of aspirin resistance. | 2005 | Cardiology | pmid:16020925 |
| Walsh DS et al. | Characterization of circulating monocytes expressing HLA-DR or CD71 and related soluble factors for 2 weeks after severe, non-thermal injury. | 2005 | J. Surg. Res. | pmid:16045935 |
| Rodrigue ME et al. | Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats. | 2005 | Can. J. Physiol. Pharmacol. | pmid:16049546 |
| Esser R et al. | Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2. | 2005 | Br. J. Pharmacol. | pmid:15655513 |
| Myers SI et al. | Bile duct ligation induced acute inflammation up-regulates cyclooxygenase-2 content and PGE2 release in guinea pig gallbladder smooth muscle cell cultures. | 2005 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:15850713 |
| Nakamura K et al. | Influence of preoperative administration of omega-3 fatty acid-enriched supplement on inflammatory and immune responses in patients undergoing major surgery for cancer. | 2005 | Nutrition | pmid:15925286 |
| Coppola A et al. | Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype. | 2005 | Br. J. Haematol. | pmid:16173969 |
| Blume C et al. | Different effect of cyclosporine A and mycophenolate mofetil on passive Heymann nephritis in the rat. | 2005 | Nephron Exp. Nephrol. | pmid:15855806 |
| Giraudel JM et al. | Development of in vitro assays for the evaluation of cyclooxygenase inhibitors and predicting selectivity of nonsteroidal anti-inflammatory drugs in cats. | 2005 | Am. J. Vet. Res. | pmid:15900953 |
| Song YM et al. | Effects of scorpion venom bioactive polypolypeptides on platelet aggregation and thrombosis and plasma 6-keto-PG F1alpha and TXB2 in rabbits and rats. | 2005 | Toxicon | pmid:15975616 |
| Hsiao G et al. | Protective mechanisms of inosine in platelet activation and cerebral ischemic damage. | 2005 | Arterioscler. Thromb. Vasc. Biol. | pmid:15976325 |
| Montuschi P et al. | Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD. | 2005 | Thorax | pmid:16192367 |
| Barbara J et al. | Prevention of latex sensitization in guinea pigs by a bacterial and viral filter used in anaesthesia. | 2005 | Br J Anaesth | pmid:15980041 |
| Hsiao G et al. | alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation. | 2005 | J. Agric. Food Chem. | pmid:15969494 |
| Wu CC et al. | 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. | 2005 | Eur. J. Pharmacol. | pmid:16313903 |
| Munsterhjelm E et al. | Characterization of inhibition of platelet function by paracetamol and its interaction with diclofenac in vitro. | 2005 | Acta Anaesthesiol Scand | pmid:15954969 |
| Vangroenweghe F et al. | Effect of carprofen treatment following experimentally induced Escherichia coli mastitis in primiparous cows. | 2005 | J. Dairy Sci. | pmid:15956299 |
| Wakamoto S et al. | Effects of hemoglobin vesicles on resting and agonist-stimulated human platelets in vitro. | 2005 | Artif Cells Blood Substit Immobil Biotechnol | pmid:15960075 |
| Al Kadi H et al. | A prospective, longitudinal study of the renin-angiotensin system, prostacyclin and thromboxane in the first trimester of normal human pregnancy: association with birthweight. | 2005 | Hum. Reprod. | pmid:16006463 |
| Beretta C et al. | COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis. | 2005 | Pharmacol. Res. | pmid:15939622 |
| Klein Gunnewiek JM et al. | The influence of acetylsalicylic acid intake by healthy volunteers on duplicate PFA-100 measurements. | 2005 | Blood Coagul. Fibrinolysis | pmid:15970717 |
| Visioli F et al. | Virgin Olive Oil Study (VOLOS): vasoprotective potential of extra virgin olive oil in mildly dyslipidemic patients. | 2005 | Eur J Nutr | pmid:15309433 |
| Jin YR et al. | Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization. | 2005 | J. Pharmacol. Exp. Ther. | pmid:15328379 |
| Jin YR et al. | An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets. | 2005 | Basic Clin. Pharmacol. Toxicol. | pmid:16128910 |
| Zhu S et al. | [Influence of Minkeqing oral liquid on IL-6, IL-8, ET-1, TX-B2 in blood and to observe bronchoalveolar lavage fluid of the rat with inhalating ovalbumin]. | 2005 | Zhongguo Zhong Yao Za Zhi | pmid:16161448 |
| Corazzi T et al. | Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016). | 2005 | J. Pharmacol. Exp. Ther. | pmid:16144976 |
| Haubelt H et al. | Can platelet function tests predict the clinical efficacy of aspirin? | 2005 | Semin. Thromb. Hemost. | pmid:16149017 |
| Ueda T and Hashimoto T | [Thromboxane A2 (TXA2), thromboxane B2 (TXB2)]. | 2005 | Nippon Rinsho | pmid:16149442 |
| Francois H et al. | Prostacyclin protects against elevated blood pressure and cardiac fibrosis. | 2005 | Cell Metab. | pmid:16154102 |
| Jermany J et al. | Lumiracoxib does not affect the ex vivo antiplatelet aggregation activity of low-dose aspirin in healthy subjects. | 2005 | J Clin Pharmacol | pmid:16172182 |
| Persico N et al. | Transdermal HRT and Doppler findings in normotensive and hypertensive postmenopausal patients. | 2005 | Ultrasound Obstet Gynecol | pmid:16184506 |
| Perini JA et al. | Influence of CYP2C9 genotypes on the pharmacokinetics and pharmacodynamics of piroxicam. | 2005 | Clin. Pharmacol. Ther. | pmid:16198655 |
| Davì G et al. | Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. | 2005 | Arterioscler. Thromb. Vasc. Biol. | pmid:15472127 |
| Maree AO et al. | Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease. | 2005 | J. Am. Coll. Cardiol. | pmid:16198840 |
| Kataoka M et al. | A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension. | 2005 | Am. J. Respir. Crit. Care Med. | pmid:16192456 |
| Cao D et al. | Chronic administration of ethyl docosahexaenoate decreases mortality and cerebral edema in ischemic gerbils. | 2005 | Life Sci. | pmid:16214179 |
| Léger CL et al. | A thromboxane effect of a hydroxytyrosol-rich olive oil wastewater extract in patients with uncomplicated type I diabetes. | 2005 | Eur J Clin Nutr | pmid:15798774 |
| Stichtenoth DO et al. | Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers. | 2005 | Kidney Int. | pmid:16221219 |
| Saloheimo P et al. | Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. | 2005 | Thromb. Res. | pmid:15733969 |
| Trebino CE et al. | Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages. | 2005 | J. Biol. Chem. | pmid:15722356 |
| Fimognari FL et al. | Nocturnal rise of urinary thromboxane B 2 in patients with coronary artery disease. | 2005 | Thromb. Haemost. | pmid:15735822 |
| Mayer AM et al. | Differential modulation of microglia superoxide anion and thromboxane B2 generation by the marine manzamines. | 2005 | BMC Pharmacol. | pmid:15762999 |
| Kalaitzis C et al. | Effects of renal denervation of the contralateral kidney on blood pressure and sodium and eicosanoid excretion in the chronic phase of two-kidney, one-clip renovascular hypertension in rats. | 2005 | Scand. J. Urol. Nephrol. | pmid:15764265 |
| GarcÃa-Saura MF et al. | Effects of chronic quercetin treatment in experimental renovascular hypertension. | 2005 | Mol. Cell. Biochem. | pmid:15792364 |
| Awad AS et al. | Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats. | 2005 | Am. J. Hypertens. | pmid:15831366 |
| De Candia E et al. | Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X. | 2005 | Int. J. Cardiol. | pmid:15837078 |
| Capone ML et al. | Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects. | 2005 | J. Am. Coll. Cardiol. | pmid:15837265 |
| Oliveira RL et al. | Postmenopausal hormone replacement therapy increases plasmatic thromboxane beta 2. | 2005 | Int. J. Cardiol. | pmid:15771927 |
| Cryer B et al. | Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers. | 2005 | Clin Ther | pmid:15811481 |
| Lappegård KT et al. | Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoid production. | 2005 | Ann. Thorac. Surg. | pmid:15734405 |
| Yao X et al. | [The changes of some vasoactive substances after operation in patients with obstructive sleep apnea-hypopnea syndrome]. | 2005 | Lin Chuang Er Bi Yan Hou Ke Za Zhi | pmid:16398051 |
| Kong XY and Gong PL | [Effect of phenolic alkaloids of Menispermum dauricum on thrombosis and platelet aggregation]. | 2005 | Yao Xue Xue Bao | pmid:16408809 |
| Gerasimovska-Kitanovska B et al. | Decreased nitric oxide in women with essential hypertension in prehypertensive phase. | 2005 | Croat. Med. J. | pmid:16342341 |